Back to Search
MICHAEL SCHWARTZMAN, D.O.
D.O.
Neurology Physician
NPI: 1245278712IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
05-26084(KS)R3L28(MO)
CMS Specialties
PrimaryNEUROLOGY
Education
DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Class of 1984
Research & Publications (20)
20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling.
PMID 18156192·Am J Physiol Heart Circ Physiol·2008
7-preclinical
Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury.
PMID 18441305·Invest Ophthalmol Vis Sci·2008
7-preclinical
Astrocyte-derived CO is a diffusible messenger that mediates glutamate-induced cerebral arteriolar dilation by activating smooth muscle Cell KCa channels.
PMID 17991880·Circ Res·2008
8-other
Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1.
PMID 17991614·Prostaglandins Other Lipid Mediat·2007
7-preclinical
Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.
PMID 17548721·Hypertension·2007
7-preclinical
11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.
PMID 17164143·Prostaglandins Other Lipid Mediat·2007
8-other
Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects.
PMID 16959961·J Pharmacol Exp Ther·2006
7-preclinical
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase.
PMID 16798831·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction.
PMID 16524951·J Am Soc Nephrol·2006
7-preclinical
Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.
PMID 16316349·Kidney Int·2005
7-preclinical
Transplantation and 6-month follow-up of renal transplantation from a donor with systemic lupus erythematosus and lupus nephritis.
PMID 15943638·Am J Transplant·2005
5-case
Case report: IgM type of membranous glomerulopathy in a diabetic patient.
PMID 15943183·Ann Clin Lab Sci·2005
5-case
Acute cellular rejection predominated by monocytes is a severe form of rejection in human renal recipients with or without Campath-1H (alemtuzumab) induction therapy.
PMID 15707416·Am J Transplant·2005
8-other
Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.
PMID 15228236·Ann Clin Lab Sci·2004
5-case
Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury.
PMID 15086901·Kidney Int·2004
7-preclinical
Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells.
PMID 12623985·Hypertension·2003
8-other
Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension.
PMID 12531784·Am J Physiol Regul Integr Comp Physiol·2003
7-preclinical
COX-2 lack of function in hypoxia-induced ocular surface inflammation.
PMID 14592551·Thromb Res·2003
7-preclinical
Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells.
PMID 11752115·J Pharmacol Exp Ther·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4400 BROADWAY, SUITE 520
KANSAS CITY, MO 64111 - Phone
- (816) 531-4080
Quick Facts
- NPI
- 1245278712
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile